MDXG · Mimedx Group, Inc. · Documents

$3.27 -0.05 (-1.36%) Play latest call Q3 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Customer concentration — top 10 customers 22% of revenue

10 customers — 22% of revenue (the year ended December 31, 2025)

“For the years ended December 31, 2025, 2024, and 2023, our top ten customers accounted for 22%, 20% and 20%, respectively, of our net sales”

Key customers — 1% of revenue (the year ended December 31, 2025)

“net sales to all U.S. government accounts comprised approximately 1%, 1% and 2%, respectively, of our net sales.”

10 customers — 20% of revenue (the year ended December 31, 2024)

“For the years ended December 31, 2025, 2024, and 2023, our top ten customers accounted for 22%, 20% and 20%, respectively, of our net sales”

Key customers — 1% of revenue (the year ended December 31, 2024)

“net sales to all U.S. government accounts comprised approximately 1%, 1% and 2%, respectively, of our net sales.”

10 customers — 20% of revenue (the year ended December 31, 2023)

“For the years ended December 31, 2025, 2024, and 2023, our top ten customers accounted for 22%, 20% and 20%, respectively, of our net sales”

Key customers — 2% of revenue (the year ended December 31, 2023)

“net sales to all U.S. government accounts comprised approximately 1%, 1% and 2%, respectively, of our net sales.”

View the 10-K filed Feb 25, 2026

Market Cap

$483.01M

145.93M

Volume · Nov 9 116.5K Avg daily vol (3M) 1.32M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2020

Aug 3

Proxy statement DEF 14A

Proxy statement

Aug 3

Proxy statement DEFA14A

Proxy statement

Jul 28

Current report 8-K

Regulation FD disclosure

Jul 27

Current report 8-K Events of Jul 21

Director or officer change, or executive pay

Jul 21

Current report 8-K

Other events

Jul 15

Current report 8-K Events of Jul 9

Ended a material agreement

Jul 6

Current report 8-K Events of Jul 2

Financial results, Regulation FD disclosure

Jul 6

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Revenue $61.74M ▼ 7.2% Net loss $4.82M Diluted EPS -$0.04

Jul 6

Quarterly report 10-Q FY2019 Q1, ended Mar 31

Quarterly report for FY2019 Q1

Revenue $66.56M ▼ 20.9% Net loss $13.27M Diluted EPS -$0.12

Jul 6

Quarterly report 10-Q FY2019 Q2, ended Jun 30

Quarterly report for FY2019 Q2

Revenue $67.44M ▼ 29.3% Net loss $17.21M Diluted EPS -$0.16

Jul 6

Quarterly report 10-Q FY2019 Q3, ended Sep 30

Quarterly report for FY2019 Q3

Revenue $88.86M ▲ 2.2% Net income $12.38M Diluted EPS $0.11

Jul 6

Annual report 10-K FY2019, ended Dec 31

Annual report for FY2019

Revenue $299.26M ▼ 16.7% Net loss $25.58M Diluted EPS -$0.24

May 11

Current report 8-K Events of May 8

Ended a material agreement, Regulation FD disclosure

May 11

Late filing notice NT 10-Q

Late filing notice

May 5

Current report 8-K Events of May 1

Director or officer change, or executive pay, Regulation FD disclosure

Apr 27

Current report 8-K Events of Apr 21

Entered into a material agreement, New debt or off-balance-sheet obligation

Apr 21

Current report 8-K

Regulation FD disclosure

Apr 16

Current report 8-K

Regulation FD disclosure

Apr 6

Current report 8-K

Regulation FD disclosure

Mar 19

Current report 8-K Events of Mar 18

Director or officer change, or executive pay

Mar 18

Current report 8-K Events of Mar 17

Financial results, Regulation FD disclosure

Mar 18

Late filing notice NT 10-K

Late filing notice

Mar 17

Annual report 10-K FY2018, ended Dec 31

Annual report for FY2018

Revenue $359.11M ▲ 11.8% Net loss $29.98M Diluted EPS -$0.28

Showing 201–223 of 223 documents

Key facts CIK 1376339 CUSIP 602496101 13F (30d) 101 filings 89 filers Visit website Investor relations